Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AAO, Ablynx, abroad, abrogate, accommodate, acknowledged, ActRIIB, AEs, Alder, alirocumab, anemia, anniversary, appoint, APTC, area, Asian, attention, bacteria, BCVA, beta, bioactivity, brand, branded, bribery, British, calibrator, capable, cataract, Celgene, Center, cessation, Chancery, CHOICE, chronic, circumstance, compounding, conference, conspiracy, constitute, consultant, consummated, consummation, contamination, contemplated, cooperation, cycle, death, dedicate, Denmark, designee, devise, dissemination, divert, Division, Dr, dry, dupilumab, earliest, engineered, English, enoticumab, EURETINA, euro, exhaustive, expiratory, export, ezetimibe, fasinumab, FCPA, feasibility, foot, FovistaTM, fungi, FV, Geisinger, genotyping, handle, HIPAA, inconclusive, influenza, inside, invented, Ireland, joined, Justice, Kymab, landry, lender, lengthening, ligand, Limerick, London, long, Mill, MONO, monocolonal, myopic, nasal, nausea, nesvacumab, neurocognitive, neutrophil, Nordisk, Novo, NQ, official, oncolytic, opt, overview, Pennsylvania, Physician, plasma, platelet, political, Poor, pound, predicated, prevailing, promulgated, reader, renovate, repay, RGC, River, Road, robert, Russia, SAE, sanctioned, scFv, shift, skeletal, sterling, strength, subset, Sunshine, teaching, telephone, Thoracic, thromboembolic, topical, TR, traumatic, unfamiliar, unmet, upfront, urinary, Venereology, yen
Removed:
Abbott, Aerovance, alternative, bid, Biotech, Bridgewater, canceling, caption, Centocor, complaint, counterclaim, dated, declaratory, EMA, examination, excluding, exempt, existed, financed, goal, goldberg, inception, inconsequential, Institute, investigating, Jersey, Latin, murray, opposed, optimize, Ortho, precluding, premium, proportional, recovered, recruitment, secure, SERI, Servier, Singapore, Southern, Squib, subjective, sublease, suggest, targeted, taxable, traditional, tyrosine, undertaken, VelociSuiteTM, VELOUR, Xoma
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1.10 Amendment No. 1 to the Second Amended and Restated 2000 Long-term Incentive Plan
- 21.1 Subsidiaries of Regeneron Pharmaceuticals, Inc
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A)
- 32 Certification of CEO and CFO Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Related press release
REGN similar filings
Filing view
External links